Personalized medicine and genome-based treatments: Why personalized medicine ≠ individualized treatments

about

Identification of translational dermatology research priorities in the U.K.: results of an electronic Delphi exercise From "Personalized" to "Precision" Medicine: The Ethical and Social Implications of Rhetorical Reform in Genomic Medicine.

P2860

Q37289465-8EAB3930-C6A2-4FB8-B831-A2F4FA221FE1 Q37497641-9EDAA0C6-CCC4-465A-A1F0-0A79FD1AA9E6

P2860

Personalized medicine and genome-based treatments: Why personalized medicine ≠ individualized treatments

Item

http://www.wikidata.org/entity/Q57519272

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2014

@uk

name

Personalized medicine and geno ...... ne ≠ individualized treatments

@en

Personalized medicine and geno ...... ne ≠ individualized treatments

@nl

type

Item

label

Personalized medicine and geno ...... ne ≠ individualized treatments

@en

Personalized medicine and geno ...... ne ≠ individualized treatments

@nl

prefLabel

Personalized medicine and geno ...... ne ≠ individualized treatments

@en

Personalized medicine and geno ...... ne ≠ individualized treatments

@nl

P1476

Personalized medicine and geno ...... ne ≠ individualized treatments

@en

P2093

BJ Wilson

http://www.w3.org/2001/XMLSchema#string

H Etchegary

http://www.w3.org/2001/XMLSchema#string

JC Carroll

http://www.w3.org/2001/XMLSchema#string

SG Nicholls

http://www.w3.org/2001/XMLSchema#string

P2860

Epigenetic differences arise during the lifetime of monozygotic twins

The genetic basis for cancer treatment decisions

The $1,000 genome, the $100,000 analysis?

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother

Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate

The utility and predictive value of combinations of low penetrance genes for screening and risk prediction of colorectal cancer.

Clinical interpretation and implications of whole-genome sequencing.

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts.

DNA methylation profiles in monozygotic and dizygotic twins.

P304

135-144

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1477750914558556

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David Castle

P577

2014-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

Personalized medicine and genome-based treatments: Why personalized medicine ≠ individualized treatments

about

P2860

P2860

Personalized medicine and genome-based treatments: Why personalized medicine ≠ individualized treatments

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577